The third phase of clinical trials for a COVID-19 vaccine has begun in Abu Dhabi.
The chairman of the Department of Health- Abu Dhabi (DoH), Sheikh Abdullah bin Mohammed Al Hamed is the first person to participate in the trial.
Dr. Jamal Al Kaabi, Acting Undersecretary of DoH will be the second in line.
The trials are being performed by Abu Dhabi-based G42 Healthcare in cooperation with China's Sinopharm CNBG, under the administration of the DoH and the UAE's Ministry of Health.
عبد الله بن محمد آل حامد، رئيس دائرة الصحة بأبوظبي، أول متطوع يشارك في التجارب السريرية التي تجري في #أبوظبي للمرحلة الثالثة من اللقاح غير النشط لوباء كوفيد-19، يليه الدكتور جمال الكعبي، وكيل دائرة الصحة بالإنابة، وهو الأمر الذي يعكس التزام الإمارة بإيجاد علاج عالمي للوباء. pic.twitter.com/TX6AJPxJh3
— مكتب أبوظبي الإعلامي (@ADMediaOffice) July 16, 2020
It's the world’s first WHO-listed phase III clinical trial of the COVID-19 inactivated vaccine.
The world’s first @WHO-listed phase III clinical trial of the Covid-19 inactivated vaccine has begun in #AbuDhabi, with @DoHSocial Chairman, Sheikh Abdullah bin Mohammed Al Hamed the 1st to participate in the trial, followed by Acting Undersecretary Dr. Jamal Al Kaabi. pic.twitter.com/gEIFgcSFHC
— مكتب أبوظبي الإعلامي (@ADMediaOffice) July 16, 2020
The UAE's plans to launch the trials were announced last month, while earlier this week, Minister of Health and Prevention, Dr. Abdul Rahman Al Owais revealed more than 15,000 volunteers will be participating.
UAE Ministry of Foreign Affairs issues travel advisory amid regional tensions
Fire in Dubai Marina high-rise contained after six hours
H.H. Sheikh Abdullah concludes visit to US to bolster bilateral cooperation
UAE foreign minister, global counterparts discuss regional developments
Jaywalking and scooter misuse claim 13 lives in Dubai
Watch: Abu Dhabi hosts test flight of pilotless air taxi
UAE carriers suspend, reroute flights after Israel strikes Iran
MBRGI completes major anti-malnutrition projects in Africa
